Oliver Nayler

Years Active: 2018-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Marchesin, Lucile Monnier, Peter Blattmann, Florent Chevillard, Christine Kuntz, Camille Forny, Judith Kamper, Rolf Studer, Alexandre Bossu, Eric A Ertel, Oliver Nayler, Christine Brotschi, Jodi T Williams, John Gatfield
A uniquely efficacious type of CFTR corrector with complementary mode of action. Science advances 10 (9) (2024)
Valentina Marchesin, Lucile Monnier, Peter Blattmann, Florent Chevillard, Christine Kuntz, Camille Forny, Judith Kamper, Rolf Studer, Alexandre Bossu, Eric A Ertel, Oliver Nayler, Christine Brotschi, Jodi T Williams, John Gatfield
A uniquely efficacious type of CFTR corrector with complementary mode of action. Science advances 10 (9) (2024)
Luca Piali, Magdalena Birker-Robaczewska, Cyrille Lescop, Sylvie Froidevaux, Nicole Schmitz, Keith Morrison, Christopher Kohl, Markus Rey, Rolf Studer, Enrico Vezzali, Patrick Hess, Martine Clozel, Beat Steiner, Martin H Bolli, Oliver Nayler
Cenerimod, a novel selective S1P1 receptor modulator with unique signaling properties. Pharmacology research & perspectives 5 (6) (2018)

Oliver Nayler.css-eqlu8i{font-size:small;padding-left:4px;}